4.6 Article

A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells

Related references

Note: Only part of the references are listed.
Review Cell Biology

Autophagy and human disease

Ju Huang et al.

CELL CYCLE (2007)

Article Biochemistry & Molecular Biology

Time-dependent inhibition of isoprenylcysteine carboxyl methyltransferase by indole-based small molecules

Rudi A. Baron et al.

BIOCHEMISTRY (2007)

Review Oncology

Autophagy in cancer: Good, bad, or both?

Melanie M. Hippert et al.

CANCER RESEARCH (2006)

Review Biochemistry & Molecular Biology

Therapeutic intervention based on protein prenylation and associated modifications

Michael H. Gelb et al.

NATURE CHEMICAL BIOLOGY (2006)

Review Biochemistry & Molecular Biology

mTOR and cancer therapy

J. B. Easton et al.

ONCOGENE (2006)

Article Oncology

Opinion - Post-prenylation-processing enzymes as new targets in oncogenesis

AM Winter-Vann et al.

NATURE REVIEWS CANCER (2005)

Review Cell Biology

Fatty acylation and prenylation of proteins: what's hot in fat

T Magee et al.

CURRENT OPINION IN CELL BIOLOGY (2005)

Article Multidisciplinary Sciences

A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells

AM Winter-Vann et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Oncology

The role of autophagy in cancer development and response to therapy

Y Kondo et al.

NATURE REVIEWS CANCER (2005)

Article Biochemistry & Molecular Biology

Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

T Kanzawa et al.

CELL DEATH AND DIFFERENTIATION (2004)

Article Medicine, Research & Experimental

Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf

MO Bergo et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Oncology

Will mTOR inhibitors make it as cancer drugs?

CL Sawyers

CANCER CELL (2003)

Review Pharmacology & Pharmacy

Farnesyltransferase inhibitors: promises and realities

AD Cox et al.

CURRENT OPINION IN PHARMACOLOGY (2002)

Article Multidisciplinary Sciences

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR

MS Neshat et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Multidisciplinary Sciences

Proliferation, cell cycle and apoptosis in cancer

GI Evan et al.

NATURE (2001)